Together, these recent findings show an emerging role of OGT and O-GlcNAc in regulating ferroptosis and survival (Fig. 2), and targeting the O-GlcNAc cycle in combination with ferroptosis-inducing drugs could be a potential approach to targeting cancer. This evidence concerns the gene OGT and cancer.